• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实施严重精神疾病循证护理的新工具。

New Tools for Implementing Evidence-Based Care for Serious Mental Illness.

作者信息

Cohen Amy N, Gorrindo Tristan

机构信息

American Psychiatric Association, Washington, D.C.

出版信息

Focus (Am Psychiatr Publ). 2020 Oct;18(4):432-435. doi: 10.1176/appi.focus.20200023. Epub 2020 Nov 5.

DOI:10.1176/appi.focus.20200023
PMID:33343255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7725150/
Abstract

More than 11 million adults in the United States have a serious mental illness. Outcomes for these illnesses are good when appropriate treatments are received; however, rates of delivery and utilization of evidence-based care for this population are moderate to low. This article introduces SMI Adviser, a national initiative, supported by the Substance Abuse and Mental Health Services Administration, to advance the use of evidence-based practices and delivery of patient-centered care for the population with serious mental illness. SMI Adviser offers free technical assistance to clinicians caring for this population through accredited educational opportunities, vetted resources, and on-demand consultations.

摘要

美国有超过1100万成年人患有严重精神疾病。如果接受适当治疗,这些疾病的治疗效果良好;然而,针对这一人群的循证护理的提供率和利用率处于中等至较低水平。本文介绍了“严重精神疾病顾问”(SMI Adviser),这是一项由药物滥用和精神健康服务管理局支持的全国性倡议,旨在推广循证实践的应用,并为患有严重精神疾病的人群提供以患者为中心的护理。“严重精神疾病顾问”通过经认可的教育机会、经过审核的资源和按需咨询,为照顾这一人群的临床医生提供免费技术援助。

相似文献

1
New Tools for Implementing Evidence-Based Care for Serious Mental Illness.实施严重精神疾病循证护理的新工具。
Focus (Am Psychiatr Publ). 2020 Oct;18(4):432-435. doi: 10.1176/appi.focus.20200023. Epub 2020 Nov 5.
2
End-of-Life Care in Individuals With Serious Mental Illness.严重精神疾病患者的临终关怀。
Psychosomatics. 2020 Sep-Oct;61(5):428-435. doi: 10.1016/j.psym.2020.06.003. Epub 2020 Jun 12.
3
Consideration of the influence of place on access to employment for persons with serious mental illness in northeastern Ontario.安大略省东北部地区对严重精神疾病患者就业机会获取的影响因素考量。
Rural Remote Health. 2012;12:2034. Epub 2012 Jul 30.
4
Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).高效抗逆转录病毒疗法(HAART)治疗合并严重精神疾病的HIV感染者的成本。
J Ment Health Policy Econ. 2009 Dec;12(4):187-94.
5
Leveraging Digital Medicine to Support Providers and Their Patients in Managing Serious Mental Illness.利用数字医疗为提供者及其患者管理严重精神疾病提供支持。
Popul Health Manag. 2021 Aug;24(S2):S55-S61. doi: 10.1089/pop.2021.0083.
6
Posttransplantation Outcomes in Veterans With Serious Mental Illness.患有严重精神疾病的退伍军人的移植后结局
Transplantation. 2015 Aug;99(8):e57-65. doi: 10.1097/TP.0000000000000616.
7
8
A mixed methods exploration of family involvement in medical care for older adults with serious mental illness.混合方法探索家庭在老年严重精神疾病患者医疗中的参与。
Int J Psychiatry Med. 2014;48(2):121-33. doi: 10.2190/PM.48.2.e.
9
Building The Mental Health Workforce Capacity Needed To Treat Adults With Serious Mental Illnesses.建设治疗重度精神疾病成年人所需的心理健康劳动力能力。
Health Aff (Millwood). 2016 Jun 1;35(6):983-90. doi: 10.1377/hlthaff.2015.1619.
10
Gender differences in service utilization among Operations Enduring Freedom, Iraqi Freedom, and New Dawn Veterans Affairs patients with severe mental illness and substance use disorders.患有严重精神疾病和物质使用障碍的“持久自由行动”、“伊拉克自由行动”和“新黎明行动”退伍军人事务患者的服务利用中的性别差异。
Psychol Serv. 2018 Feb;15(1):11-20. doi: 10.1037/ser0000144. Epub 2017 May 18.

引用本文的文献

1
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia.阿立哌唑劳罗西酯:一种用于治疗精神分裂症的长效注射用非典型抗精神病药物的研发及循证综述
Neuropsychiatr Dis Treat. 2025 Mar 14;21:575-596. doi: 10.2147/NDT.S499367. eCollection 2025.
2
Integration of Psychiatric Advance Directives Into the Patient-Accessible Electronic Health Record: Exploring the Promise and Limitations.将精神科预立医疗指示纳入患者可访问的电子健康记录:探索前景与局限
J Med Internet Res. 2025 Mar 18;27:e68549. doi: 10.2196/68549.
3
Arrestin-3 Agonism at Dopamine D Receptors Defines a Subclass of Second-Generation Antipsychotics That Promotes Drug Tolerance.多巴胺 D 受体激动剂抑制蛋白-3 定义了第二代抗精神病药物的一个亚类,该亚类可促进药物耐受。
Biol Psychiatry. 2023 Oct 1;94(7):531-542. doi: 10.1016/j.biopsych.2023.03.006. Epub 2023 Mar 15.

本文引用的文献

1
Impact of psychiatric advance directive facilitation on mental health consumers: empowerment, treatment attitudes and the role of peer support specialists.精神科预嘱促进对心理健康消费者的影响:赋权、治疗态度和同伴支持专家的作用。
J Ment Health. 2021 Oct;30(5):585-593. doi: 10.1080/09638237.2020.1714008. Epub 2020 Feb 4.
2
Psychiatric Advance Directives: Origins, Benefits, Challenges, and Future Directions.精神科预先指示:起源、益处、挑战及未来方向。
J Psychiatr Pract. 2019 Jul;25(4):303-307. doi: 10.1097/PRA.0000000000000401.
3
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics.难治性精神分裂症:抗精神病药物基因组学的当前见解
Pharmgenomics Pers Med. 2016 Nov 7;9:117-129. doi: 10.2147/PGPM.S115741. eCollection 2016.
4
Individual Placement And Support Services Boost Employment For People With Serious Mental Illnesses, But Funding Is Lacking.个体安置与支持服务促进了严重精神疾病患者的就业,但资金短缺。
Health Aff (Millwood). 2016 Jun 1;35(6):1098-105. doi: 10.1377/hlthaff.2016.0001.
5
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.双相情感障碍治疗的循证指南:英国精神药理学会修订第三版建议
J Psychopharmacol. 2016 Jun;30(6):495-553. doi: 10.1177/0269881116636545. Epub 2016 Mar 15.
6
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.归因于精神和物质使用障碍的疾病全球负担:来自 2010 年全球疾病负担研究的结果。
Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29.
7
Psychiatric advance directives and reduction of coercive crisis interventions.精神科预先指示与减少强制性危机干预
J Ment Health. 2008 Jan 1;17(3):255-267. doi: 10.1080/09638230802052195.
8
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.2009 年精神分裂症 PORT 精神药理学治疗建议和总结陈述。
Schizophr Bull. 2010 Jan;36(1):71-93. doi: 10.1093/schbul/sbp116. Epub 2009 Dec 2.
9
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.2009 年精神分裂症 PORT 心理社会治疗建议和总结陈述。
Schizophr Bull. 2010 Jan;36(1):48-70. doi: 10.1093/schbul/sbp115. Epub 2009 Dec 2.
10
The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.精神分裂症患者结局研究团队(PORT):2009 年更新的治疗推荐。
Schizophr Bull. 2010 Jan;36(1):94-103. doi: 10.1093/schbul/sbp130. Epub 2009 Dec 2.